Advanced MS system set to accelerate peptide bioanalysis

Veloxity Labs, a US-based bioanalytical CRO focused on rapid, high-quality support for complex programs, is expanding its analytical capacity with the acquisition of a cutting-edge accurate mass spectrometer. The move makes Veloxity the first CRO in the United States to bring the SCIEX ZenoTOF 8600 system online, with delivery scheduled later this year and installation beginning January 2026.

The new system strengthens Veloxity’s toolkit for peptide and protein analysis, improving method development, interference resolution, and identity confirmation. It complements existing triple quadrupole LC–MS/MS platforms while providing additional sensitivity and selectivity for challenging workflows, including GLP-1 receptor agonists and other peptide therapeutics.

“Adding the ZenoTOF 8600 enables our scientists to tackle complex bioanalytical challenges faster and with greater confidence,” said Shane Needham, PhD, Co-Founder, President & CEO of Veloxity Labs. “This investment accelerates method cycles and enhances our ability to manage interferences, delivering immediate benefits for our sponsors’ timelines.”

The acquisition is part of a broader lab expansion plan that will include an additional instrument lab, more freezer storage, and increased capacity for the growing Veloxity team. The ZenoTOF 8600 system supports high-resolution, accurate mass workflows, giving researchers the flexibility to perform sensitive, selective analyses across discovery, GLP, and early clinical stages.

Jose Castro-Perez, VP of Product Management at SCIEX, added: “Veloxity’s early adoption of the ZenoTOF 8600 demonstrates the platform’s power in resolving complex bioanalytical problems. Their focus on efficiency and scientific rigor makes them an ideal partner to showcase its capabilities.”

The ZenoTOF 8600 will allow Veloxity to expand throughput, confidence, and selectivity in peptide workflows, ensuring smooth transitions from discovery to clinical studies while maintaining high-quality, GLP-aligned practices.

More information online